LSU Health’s Taylor Appointed to NIH Advisory Council

October 20, 2021

Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases, welcomed Stephanie Taylor, MD, professor of medicine and microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, as one of two new members of the National Institute of Allergy and Infectious Diseases (NIAID) Council at her first Council meeting. She is the only NIAID Council member from Louisiana. The Council is the chief advisory committee of the NIAID. It comprises 18 voting members serving on three subcommittees corresponding to NIAID extramural divisions.. Dr. Taylor is one of five members of the Microbiology and Infectious Diseases (DMID) Subcommittee. Members usually serve for four years but can serve 180 days longer if their successor has not been appointed.

According to NIAID, among its duties, the NIAID Council advises NIAID on policy, clears concepts, and reviews programs. NIAID often seeks the Council's advice before changing policies for training, health information dissemination, administration, budget, and other areas. The NIAID Council also advises on long-term planning of potential future NIAID initiatives. Council members and ad hoc advisors counsel the Institute on broad research priorities and directions, providing the perspective of the outside community.

Follow Us

Media Contact

Leslie Capo

Office: 504-568-4806

Cell: 504-452-9166

lcapo@lsuhsc.edu

Dr. Taylor is board certified in both Internal Medicine and Infectious Diseases, and her clinical practice and research focus on sexually transmitted infections, STI-related diagnostic trials and STI clinical drug trials. She has 80 journal publications, including one as lead author in the prestigious New England Journal of Medicine. Dr. Taylor is medical director of the LSU Infectious Diseases STD program and laboratory, the LSU-CrescentCare Sexual Health Center, and the Louisiana Office of Public Health STD/HIV Program. She is also a recipient of a Distinguished Career Achievement Award from the American STD Association and is an associate editor of Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America.

“Dr. Taylor is one of our most talented physician-scientists,” says Dr. Steve Nelson, LSU Health New Orleans Interim Chancellor and School of Medicine Dean. “This appointment reflects the excellence of LSU Health New Orleans faculty and the enormous contributions they make to Louisiana and the nation.”

______________________________________________________________________________________________________________ LSU Health Sciences Center New Orleans (LSU Health New Orleans) educates Louisiana's health care professionals. The state's health sciences university leader, LSU Health New Orleans includes a School of Medicine with branch campuses in Baton Rouge and Lafayette, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSU Health New Orleans faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research, the LSU Health New Orleans research enterprise generates jobs and enormous annual economic impact. LSU Health New Orleans faculty have made lifesaving discoveries and continue to work to prevent, advance treatment or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHealthNO, or http://www.facebook.com/LSUHSC.

NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. Among the 27 Institutes and Centers that comprise the National Institutes of Health, NIAID has a unique mandate, which requires the Institute to respond to emerging public health threats. Toward this end, NIAID manages a complex and diverse research portfolio that aims to do expand the breadth and depth of knowledge in all areas of infectious, immunologic, and allergic diseases and develop flexible domestic and international research capacities to respond appropriately to emerging and re-emerging disease threats at home and abroad. NIAID advances the understanding, diagnosis, and treatment of many of the world’s most intractable and widespread diseases. Key research areas include newly emerging and re-emerging infectious diseases such as tuberculosis and influenza, HIV/AIDS, biodefense, and immune-mediated diseases including asthma and allergy. Learn more at https://www.niaid.nih.gov/.